Group B streptococcus alpha-like surface protein family (Alp family)

The Group B streptococcus alpha-like surface protein family (Alp family) comprises highly conserved, chimeric surface-anchored proteins found in Streptococcus agalactiae (Group B streptococcus, GBS). Major family members include the Alpha C protein, Alp1 (epsilon), Alp2, Alp3, Alp4, and Rib protein[1][4][6]. These proteins are characterized by variable N-terminal regions, central tandem repeats, and C-terminal anchoring domains, leading to strain-specific molecular weights and antigenic profiles[1][4]. Functionally, Alp proteins mediate GBS binding to host epithelial cells, particularly via glycosaminoglycan interactions (notably Alpha C protein), thus promoting invasion and colonization[1][6]. They are also important for immune evasion, as their surface exposure elicits host antibody responses that can be partially cross-protective among different Alp types[1][4]. Because antibodies against these proteins can protect against GBS infection in experimental models, they are key candidates for GBS vaccine development and are being explored as vaccine antigens[1][4][6]. There is notable antigenic diversity and cross-reactivity among the Alp proteins, creating both opportunities and challenges for broad vaccine coverage in the human population[1][4]. These proteins are not direct drug targets in classical pharmacology (e.g., no small-molecule drugs), but are targets of antibody-mediated therapies and vaccines.

Other names

Alpha-like protein familyAlp familyAlpha C protein familyGBS alpha-like proteinsAlp proteins (members: Alpha C protein, Alp1/epsilon, Alp2, Alp3, Alp4, Rib protein)

Vaccine antigens: Induce antibody production leading to opsonization and immune clearance; Antibody-mediated neutralization (proposed for vaccines); Blocking bacterial adhesion to host cells